Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

73.34 -2.26 (-2.99%)
Streaming Delayed Price Updated: 12:56 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 63,276
Open 75.00
Bid (Size) 73.20 (500)
Ask (Size) 73.60 (100)
Prev. Close 75.60
Today's Range 72.95 - 75.49
52wk Range 56.71 - 99.50
Shares Outstanding 24,422,240
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Generic Pharmaceuticals Q4 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Simply the Best
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the generic pharmaceuticals industry, including ANI Pharmaceutica... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. 
Via StockStory
Topics Economy Stocks

Performance

YTD
-6.5%
-6.5%
1 Month
-8.2%
-8.2%
3 Month
-11.4%
-11.4%
6 Month
-23.6%
-23.6%
1 Year
+22.9%
+22.9%

More News

Read More
News headline image
ANI Pharma (ANIP) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
ANI Pharmaceuticals Inc (NASDAQ:ANIP) Surges 12% After Q4 Earnings Beat ↗
Via Chartmill
News headline image
ANI Pharmaceuticals (NASDAQ:ANIP) Beats Expectations in Strong Q4 CY2025, Stock Jumps 12.4%
Via StockStory
News headline image
1 Safe-and-Steady Stock Worth Your Attention and 2 That Underwhelm
Via StockStory
News headline image
3 Small-Cap Stocks That Fall Short
Via StockStory
News headline image
1 Cash-Producing Stock on Our Buy List and 2 We Brush Off
Via StockStory
Topics Supply Chain
News headline image
3 Value Stocks with Questionable Fundamentals
Via StockStory
News headline image
ANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why
Via StockStory
News headline image
Stocks making big moves yesterday: OneMain, Nextpower, ANI Pharmaceuticals, Akamai Technologies, and Lemonade
Via StockStory
News headline image
Why ANI Pharmaceuticals (ANIP) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 That Underwhelm
Via StockStory
News headline image
3 Reasons to Avoid ANIP and 1 Stock to Buy Instead
Via StockStory
Topics Stocks Supply Chain
News headline image
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Healthcare Stocks We’re Skeptical Of
Via StockStory
Topics Stocks
News headline image
3 Small-Cap Stocks We’re Skeptical Of
Via StockStory
News headline image
1 Russell 2000 Stock to Consider Right Now and 2 We Avoid
Via StockStory
News headline image
The 5 Most Interesting Analyst Questions From ANI Pharmaceuticals’s Q3 Earnings Call
Via StockStory
Topics Earnings
News headline image
Generic Pharmaceuticals Stocks Q3 Recap: Benchmarking ANI Pharmaceuticals (NASDAQ:ANIP)
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Generic Pharmaceuticals Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Simply the Best
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
The Bancorp: Building the Pulse of Digital Finance One Partnership at a Time ↗
Via The Motley Fool
News headline image
ANIP Q3 Deep Dive: Rare Disease Momentum and Generics Expansion Drive Upgraded Outlook
Via StockStory
News headline image
ANI PHARMACEUTICALS INC (NASDAQ:ANIP) Reports Record Q3 2025 Earnings, Beating Estimates ↗
Via Chartmill
News headline image
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Strong Q3 Numbers, Stock Soars
Via StockStory

Frequently Asked Questions

Is ANI Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, ANI Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does ANI Pharmaceuticals, Inc. - Common Stock trade on?
ANI Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock is ANIP on the Nasdaq Stock Market
What is the current price of ANI Pharmaceuticals, Inc. - Common Stock?
The current price of ANI Pharmaceuticals, Inc. - Common Stock is 73.34
When was ANI Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of ANI Pharmaceuticals, Inc. - Common Stock was at 03/06/26 12:56 PM ET
What is the market capitalization of ANI Pharmaceuticals, Inc. - Common Stock?
The market capitalization of ANI Pharmaceuticals, Inc. - Common Stock is 1.79B
How many shares of ANI Pharmaceuticals, Inc. - Common Stock are outstanding?
ANI Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.